Home › Compare › ASLN vs SBUX

ASLN vs SBUX: Dividend Comparison 2026

ASLN yields 333.33% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ASLN wins by $3112.08M in total portfolio value
10 years
ASLN
ASLN
● Live price
333.33%
Share price
$0.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3112.25M
Annual income
$1,957,209,378.70
Full ASLN calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — ASLN vs SBUX

📍 ASLN pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodASLNSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ASLN + SBUX cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ASLN pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ASLN
Annual income on $10K today (after 15% tax)
$28,333.33/yr
After 10yr DRIP, annual income (after tax)
$1,663,627,971.90/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, ASLN beats the other by $1,663,567,505.91/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ASLN + SBUX for your $10,000?

ASLN: 50%SBUX: 50%
100% SBUX50/50100% ASLN
Portfolio after 10yr
$1556.21M
Annual income
$978,640,257.58/yr
Blended yield
62.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

ASLN
Analyst Ratings
4
Buy
Consensus: Buy
Altman Z
-14.9
Piotroski
3/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ASLN buys
0
SBUX buys
0
No recent congressional trades found for ASLN or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricASLNSBUX
Forward yield333.33% ✓2.84%
Annual dividend / share$2.00$2.46 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3% ✓
Portfolio after 10y$3112.25M ✓$167.0K
Annual income after 10y$1,957,209,378.70 ✓$71,136.45
Total dividends collected$3000.20M ✓$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy

Year-by-year: ASLN vs SBUX ($10,000, DRIP)

YearASLN PortfolioASLN Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$44,033$33,333.33$11,121$420.68+$32.9K → ASLN
2$184,291$137,175.49$12,548$648.40+$171.7K → ASLN
3$733,748$536,556.79$14,440$1,013.98+$719.3K → ASLN
4$2,781,635$1,996,524.01$17,068$1,617.30+$2.76M → ASLN
5$10,050,002$7,073,652.70$20,912$2,649.52+$10.03M → ASLN
6$34,638,543$23,885,041.43$26,875$4,499.29+$34.61M → ASLN
7$114,000,322$76,937,080.16$36,771$8,014.12+$113.96M → ASLN
8$358,625,914$236,645,569.53$54,542$15,197.11+$358.57M → ASLN
9$1,079,474,884$695,745,156.26$89,602$31,242.49+$1079.39M → ASLN
10$3,112,247,504$1,957,209,378.70$167,011$71,136.45+$3112.08M → ASLN

ASLN vs SBUX: Complete Analysis 2026

ASLN — Stock

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

Full ASLN Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this ASLN vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ASLN vs SCHDASLN vs JEPIASLN vs OASLN vs KOASLN vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.